Jeremy Duffield's most recent trade in Prime Medicine Inc was a trade of 275,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prime Medicine Inc | Jeremy Duffield | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 275,000 | 275,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeremy Duffield | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 180,995 | 180,995 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeremy Duffield | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 180,995 | 180,995 | - | - | Stock Option (right to buy) |